|
 |
SkelaxinThis page contains recent news articles, when available, and an overview of Skelaxin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Skelaxin (when available) Metaxalone is a skeletal muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man. For the treatment of painful musculoskeletal conditions Mechanism Of Action: The mechanism of action of metaxalone in humans has not been established, but may be due to general central nervous system depression. News Articles on Metaxalone King Pharmaceuticals: A Look Ahead to Dec 2009 Quarterly Results - Dec 31, 2009 In January 2009, a US District Court acted to invalidate two of King's US patents relating to Skelaxin® (metaxalone), a muscle relaxant. ... Seeking Alpha (blog) IN RE AB - Dec 31, 2009 She was prescribed Soma earlier that week and was also taking Ativan, tramadol, and Skelaxin (a muscle relaxant), but was taken off of Celexa and Remeron ... Leagle, Inc. Falmouth District Court - Dec 18, 2009 ...operating boat under the influence of drugs (DUI), dismissed; possessing Skelaxin, dismissed upon payment of $100 court cost; possessing chloroquine, ... Cape Cod Times King Beats, but Earnings Down - Nov 5, 2009 While generic versions of Altace continued to impact the top-line, both Skelaxin and Thrombin-JMI sales continued to decline on a year-over-year basis. ... Zacks.com Generic Name: Metaxalone, pain, muscle relaxer, muscle relaxant - Nov 11, 2009 Skelaxin (generic name: Metaxalone) is a muscle relaxant with a low chance of drowsiness or side effects. It can provide relief of acute, painful muscle ... Pattaya Daily News King Pharma Income Statement Analysis for September 2009 Quarter - Nov 9, 2009 Sales of Skelaxin, the company's biggest seller, were down 7.2 percent. Animal Health products, which came from Alpharma, contributed Revenue of $95.8 ... Seeking Alpha (blog) REG-Elan Corporation PLC Elan Reports Third Quarter 2009 Financial Results - Oct 21, 2009 30 2008 2009 2008 2009 US$m US$m US$m US$m Product revenue Manufacturing revenue and royalties 16.8 14.6 Tricor® 45.6 44.6 10.9 10.2 Skelaxin® 28.3 25.8 ... Reuters King Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and ... - Nov 9, 2009 The company's product line includes Avinza, CII Skelaxin, Thrombin-JMI, Altace, Levoxyl, Cytomel, Sonata, CIV Meridian and Auto injector Products/EpiPen. ... PR-Inside.com (Pressemitteilung) King Pharma's Golden Deal - Jan 8, 2008 Metaxalone, or Skelaxin as called by King Pharmaceuticals, is a muscle relaxant used to ... Only Core has been granted any rights to Skelaxin so far. ... Forbes King Pharma to acquire Alpharma, J&J to buy Omrix - Nov 24, 2008 Bristol, Tennessee-based King, which makes the blood pressure drug Altace and muscle relaxant Skelaxin, originally offered $33 a share for Alpharma, ... Reuters King Pharma Trounces Estimates - Aug 9, 2005 Sales of Skelaxin climbed 71% to $86.8 million, and sales of Thrombin-JMI reached $52.9 million, up 67% from the comparable quarter in 2004. ... TheStreet.com - TheStreet.com (subscription) King Pharma posts 4th-qtr profit - Feb 28, 2007 Analysts expected revenue of $479.2 million. Altace sales rose 21 percent to $181 million, while Skelaxin sales jumped 61 percent to $113 million. Reuters Profits Improve at King - May 10, 2007 King extracted a 14% gain in sales to $112 million for its muscle-pain drug Skelaxin. The newly acquired Avinza, a morphine-based painkiller, contributed $9 ... TheStreet.com - TheStreet.com (subscription) Mighty Quarter for King - Aug 9, 2006 ...the blood pressure medication Altace, produced a 7%-gain in sales to $154 million. Sales of the muscle-pain treatment Skelaxin rose 12% to $97 million. TheStreet.com - TheStreet.com (subscription) King Pharmaceuticals second-quarter profit falls - Aug 7, 2007 Sales of muscle relaxant Skelaxin rose 11 percent to $108 million. The company recorded impairment charges tied to a manufacturing facility and several ... Reuters King Pharma profit falls as Altace sales dive - May 8, 2008 Sales of King's Skelaxin muscle relaxant nudged up 4 percent to $116 million. Sales of its Thrombin JMI product for controlling bleeding rose nearly 5 ... Reuters UK King Pharma profit below view; stock plunges - Aug 7, 2008 Sales of muscle relaxant Skelaxin fell roughly 1 percent to $107 million, while sales of Thrombin, a product to help stop bleeding, slipped to $64 million ... Reuters India Wednesday's Analysts' Upgrades and Downgrades - Feb 14, 2007 Stock appears fairly balanced at current levels, though investors should remain on the sidelines, until there's more clarity on the Altace and Skelaxin ... TheStreet.com - TheStreet.com (subscription) King Pharmaceuticals Reports FDA Approval of New Skelaxin(R) Label. - Dec 4, 2006 BRISTOL, Tenn. -- King Pharmaceuticals (NYSE: KG) reported today that the US Food and Drug Administration ("FDA") has approved the Company's revised ... Free with registration - Business Wire - AccessMyLibrary.com King Pharma posts higher profit - Feb 28, 2008 Sales of its Altace blood-pressure drug fell 13 percent to $158 million, while sales of its muscle relaxant Skelaxin were basically flat at $114 million. ... Reuters Skelaxin.(Used to treat painful musculoskeletal conditions)(Drug... - Dec 1, 2005 Along with rest and physical therapy, Skelaxin is prescribed for the relief of painful musculoskeletal conditions. Researchers aren't sure how the drug ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com S&P 500 Midday Leaders & Laggards - Jan 8, 2008 The company ended its patent infringement lawsuit against CorePharma LLC over the muscle relaxant drug Skelaxin. Starbucks Corp. named chairman Howard ... Boston Globe King Pharma may be bargain amid generic threat - Feb 23, 2007 ..."Skelaxin is going to be the biggest source of an upside surprise," said ... Skelaxin is King's second-biggest selling drug and expected to exceed $400 ... Reuters CorePharma to Sell Authorized Generic Skelaxin - Jan 16, 2008 King Pharmaceuticals has terminated patent litigation and entered an agreement giving CorePharma rights to an authorized generic version of Skelaxin. ... FDA news - FDA news (subscription) King Pharma ends Skelaxin patent suit; CorePharma will get generic … - Jan 11, 2008 By AP. King Pharmaceuticals Inc. said Tuesday it terminated its patent infringement lawsuit against CorePharma LLC over the muscle relaxant drug Skelaxin, ... Kingsport Times News King Pharmaceuticals swings to 3Q loss - Nov 8, 2007 Altace sales rose 6 percent to $169 million while sales of Skelaxin were flat at $106 million. Thrombin sales fell about 1 percent to $69 million. ... ABCmoney.co.uk I have been diagnosed with RA - yet have some questions from all of... - Jul 21, 2007 Currently I am taking Tramadol, Skelaxin , and a very good husband. I haven't been working since mid April and I'm sure I could not have keep up the 8 to 5. ... HealthCentral.com Loislaw Federal District Court Opinions - CLASSEN IMMUNOTHERAPIES … - Aug 16, 2006 Until 2003, Elan produced Skelaxin, a muscle relaxant. In 2001, Elan learned of a study, conducted by a generic drug manufacturer, that indicated that ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw US court finds King Pharma Altace patent invalid - Sep 11, 2007 Altace had sales of $163 million in the second quarter, while Skelaxin sales ... Altace and Skelaxin amount to more than 70 percent of King's earnings per ... Reuters Loislaw Federal District Court Opinions - CLASSEN IMMUNOTHERAPIES … - Dec 6, 2005 King acquired Skelaxin from Elan in June, 2003 and is now solely ... 5-7, but has not produced evidence that Skelaxin is manufactured using a method ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw A Compelling Case for King Pharma - Feb 26, 2007 While generic threats to principal Skelaxin and Altace drugs have increased, ... With respect to Skelaxin, we think King's planned filing of an amended ... BusinessWeek King Pharma shares drop for 2nd day after earnings - Aug 8, 2007 The Skelaxin situation is more complex but analysts are focused on an Aug. ... Cowen & Co. analyst Ian Sanderson projects Skelaxin generics in the second ... Reuters King Tumbles for Second Day - Jul 17, 2007 Skelaxin could go generic "in mid-2008, which may be extended out to 2009," says Goodman. And although King claims Skelaxin patent protection into 2021, ... TheStreet.com - TheStreet.com (subscription) Event Brief of Q1 2005 King Pharmaceuticals Earnings Conference Call ... - May 9, 2005 1Q04, particularly with respect to Altace and Skelaxin. 2. ... 1Q05 net sales of Skelaxin totaled $71.9m, 56% increase from $46.2m in 1Q04. 1. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com æ‘©æ ¹å£«ä¸¹åˆ©è°ƒé™?KG股票评级至æŒ?å¹³ - May 11, 2007 ...æ‘©æ ¹å£«ä¸¹åˆ©è¡¨ç¤ºï¼Œâ€œæˆ‘ä»¬æ¤å‰?所确定的"增æŒ?"投资æ„?è§?ï¼Œæ˜¯å› ä¸ºè¯¥å…¬å?¸å¯¹Skelaxin的业绩 预期低到ä¸?实际的底部，为投资者们æ??供了æž?佳的风险/回报比。 ... 新浪网 Texas Case Law - MILLER v. STATE, 08-03-00268-CR (Tex.App.-El Paso … - Feb 17, 2005 He also regularly took Skelaxin, a muscle relaxant, Celebrex, and Tylenol. Skelaxin was taken for his chronic back pain. Although Appellant denied that the ... Pay-Per-View - Texas Case Law - Loislaw King plunges on weak sales, inventory troubles. - Feb 28, 2006 King said the skewed information resulted in Skelaxin sales being negatively impacted by $17 million during the fourth-quarter, while Altace sales were off ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Loislaw Federal District Court Opinions - KURTH v. ASTRUE (WDWis. 7- … - Jul 30, 2008 Dr. Fanopoulos changed her Skelaxin to SOMA. On January 21, 2005, plaintiff reported diffuse pain all over. Upon examination, Dr. Fanopoulos noted tender ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw King Pharmaceuticals at JPMorgan 24th Annual Healthcare Conference - ... - Jan 12, 2006 In cardiology we sell Altace, Levoxy and Cytomel, in neuroscience Sonata, our sleep aid, and Skelaxin, our muscle relaxant. And selling those products are ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com A Compelling Case for King Pharma - Feb 26, 2007 Another risk is the success, or lack thereof, of lifecycle-management programs for Skelaxin, Altace, and Thrombin-JMI. Possible disappointments in clinical ... BusinessWeek Government moves to stop Internet advertising for X-rated spammers | ... - Jan 15, 2005 Skelaxin). Elan said it was reviewing the FTC letter and the potential impact on the ... Article: FTC ends part of Skelaxin probe AP Worldstream; May 8, ... Pay-Per-View - AP Worldstream - HighBeam Research Government moves to stop Internet advertising for X-rated spammers | ... - Jan 12, 2005 Skelaxin). Elan said it was reviewing the FTC letter and the potential impact on the ... Article: FTC ends part of Skelaxin probe AP Worldstream; May 8, ... Pay-Per-View - AP Worldstream - HighBeam Research S&P 500 August Winners - Sep 1, 2005 The key drivers during the quarter were Altace, Skelaxin and Sonata. Standard & Poor's Equity Research raised the target price on King to $13 from $10 and ... Forbes Potential Tysabri Return Lifts Biogen - Aug 15, 2005 The key drivers for the quarter were Altace, Skelaxin and Sonata, the firm said, and raised the 2005 earnings-per-share estimate on King to $1.10 from 85 ... Forbes 国王制è?¯Q4ä¸šç»©æ¬ ä½³è‚¡ä»·é‡?è·Œ16% - Mar 1, 2006 ...该公å?¸å°†é”€å”®ä¸‹æ»‘部分归咎於最畅销产å“?Skelaxinå’ŒAltace的库å˜è¶…过预期，而这主è¦?与 å…¬å?¸ä¸¤å®¶ ... 国王制è?¯ç§°ï¼Œå¤±çœŸçš„库å˜èµ„讯导致Skelaxin第四财å£çš„销售é¢?é™?低1700万 ... 新浪网 Hollingsworth v. Astrue, No. 06-5208 (WDArk. 09/19/2007) - Sep 19, 2007 Plaintiff was also regularly prescribed Voltaren XR and Skelaxin to treat her ... Records indicate that plaintiff was taking Effexor XR, Ultram, Skelaxin, ... $2.95 - U.S. District Court, Western District... - VersusLaw Mississippi Reports - PERS v. STAMPS, 2003-CC-02599-SCT (Miss. … - Apr 14, 2005 He said he prescribed her Skelaxin to alleviate the muscle spasms and if the ... At the time of the hearing, she was taking Ultram, Skelaxin, Lorazepam, ... Pay-Per-View - Mississippi Reports - Loislaw Stocks in the Spotlight Tuesday - Barrons.com - Jan 8, 2008 The drug maker surged 16.4% following the termination its patent-infringement lawsuit over the muscle-relaxant drug Skelaxin and an agreement to grant ... Subscription - Barron's Online - Dow Jones & Company Loislaw Federal District Court Opinions - MILLER v. ASTRUE (SDIowa 9-... - Sep 22, 2008 Dr. Hinnen prescribed physical therapy three times weekly, the muscle relaxant Skelaxin, and heat or ice treatment for Miller's back (Tr. 325). ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw King Pharmaceuticals Announces Strategic Acquisition of Avinza(R)... - Sep 7, 2006 ...--SKELAXIN(R) (metaxalone): A non-narcotic and non-addictive muscle ... SKELAXIN(R) is often prescribed concomitantly with analgesics such as AVINZA(R). ... Free with registration - Business Wire - AccessMyLibrary.com King Pharmaceuticals at Merrill Lynch Global Pharmaceutical, … - Feb 8, 2007 With our current product, Skelaxin, our pending acquisition of AVINZA and our ongoing development of Remoxy, and the development of T-62, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Perryman v. Astrue, No. 07-0715-M (SDAla. 04/29/2008) - Apr 29, 2008 On December 15, 2004, Dr. Moon examined Perryman and noted that her condition was, essentially, unchanged; he wrote prescriptions for Lortab,*fn3 Skelaxin ... $2.95 - U.S. District Court, Southern District... - VersusLaw Man held on gun charges - Feb 20, 2008 The officers returned to Wright's home, where they found a loaded .38-caliber handgun, a small bag of marijuana, and 16 Skelaxin pills, according to the ... Pay-Per-View - Orlando Sentinel - ProQuest Archiver King Pharmaceuticals Inc. - Jun 19, 2006 ...as Altace cardiovascular, Skelaxin muscle re-. laxant and Thrombin-JMI critical care treat- ... tion in Skelaxin, we see EPS dipping to $1.40 in ... $35.00 - Stock Reports - Standard & Poor's King Pharmaceuticals Reports Fourth-Quarter and Year-End 2004 … - Mar 17, 2005 Net sales of Skelaxin(R) totaled $81.1 million during the fourth quarter ending December 31, 2004 compared to $55.9 million in the fourth quarter of 2003. ... Free with registration - PR Newswire - AccessMyLibrary.com Drug Stocks Tempered By Lofty Expectations - Mar 6, 2006 ...uncertainty exists for the company's best-selling products, Altace and Skelaxin. Shares recovered later in the week and posted a weekly decline of 9%. ... Forbes King Pharmaceuticals Reports First-Quarter 2005 Financial Results - Sep 5, 2005 Net sales of Skelaxin(R) totaled $71.9 million during the first quarter of 2005, an increase of 56% compared to $46.2 million during the same period of the ... Euro am Sonntag FINAL TRANSCRIPT - May 1, 2008 Moving on to SKELAXIN, can you update us on the status of the patent dispute ... modeling SKELAXIN going forward? Should we expect a generic in the next two ... $54.00 - Thomson StreetEvents - Alacra Store Martin v. Astrue, No. 07-C-0186-C (WDWis. 10/04/2007) - Oct 4, 2007 He also refilled plaintiff's prescriptions for hydrocodone and Skelaxin. Plaintiff reported good relief from the injections. He did not return to the pain ... $2.95 - U.S. District Court, Western District... - VersusLaw King Pharmaceuticals Reports First-Quarter 2005 Financial Results. - May 9, 2005 Net sales of Skelaxin(R) totaled $71.9 million during the first quarter of 2005, an increase of 56% compared to $46.2 million during the same period of the ... $4.95 - PR Newswire - ECNext Glover v. Jefferson Pilot Financial Insurance Co., No. 4:06-CV-323... - Feb 21, 2007 Dr. Nunn recommended that she resume taking Skelaxin and Ibuprofen. (AR 0079). [40], By letter dated August 5, 2004, Jefferson Pilot denied Plaintiff's ... $2.95 - U.S. District Court, Eastern District... - VersusLaw Flynn v. Commissioner of the Social Security Administration, No. 6:06... - Dec 27, 2007 Id. Dr. Kollmer prescribed Ambien as needed for sleep, Skelaxin as needed for pain or spasm, and Mobic. R. 263. Physical therapy was prescribed for three ... $2.95 - U.S. District Court, Middle District of... - VersusLaw Medications for Fibromyalgia - Aug 17, 2008 Medicines in this family include Flexeril, Soma, Skelaxin, and Robaxin. The most common side effect is drowsiness, although Soma and Skelaxin cause less of ... ProHealth A Gauntlet for King Pharmaceuticals - Nov 9, 2007 Adding to the future top-line pressure, King's other top two products -- Thrombin-JMI and muscle relaxant Skelaxin -- will face competing agents entering ... fool.com King's Profits Decline | Pharmaceuticals News | Print Financial &... - Nov 9, 2006 The muscle-pain drug Skelaxin contributed $106 million, down from $116 million. King expects sales in the near future to be aided by the early September ... TheStreet.com - TheStreet.com (subscription) Press Release: King Pharmaceuticals Reports First-Quarter 2005 … - May 9, 2005 Net sales of Skelaxin(R) totaled $71.9 million during the first quarter of 2005, an increase of 56% compared to $46.2 million during the same period of the ... Pay-Per-View - PR Newswire - HighBeam Research Singleton v. Astrue, No. 3:06-CV-0760 CAN (NDInd. 02/13/2008) - Feb 13, 2008 ...[72], *fn9 Skelaxin is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, ... $2.95 - U.S. District Court, Northern District... - VersusLaw 国王制è?¯è¯„级å?‡è‡³ä¹°è¿›è‚¡ä»·å¤§æ¶¨10% - Oct 10, 2008 ...戴维斯指出，如果能将肌肉æ?¾å¼›å‰‚Skelaxin的专利ä¿?护期延ç»è‡³2009年底，或者è?¯ç›‘机构 ... å‡ å®¶ä»¿åˆ¶è?¯ç”Ÿäº§å•†ä¸€ç›´è¯•å›¾æŽ¨ç¿»Skelaxin的专利æ?ƒï¼Œä½†æˆ´ç»´æ–¯è®¤ä¸ºï¼Œåœ¨2009年底å‰? ... 新浪网 King Is in Control - May 9, 2006 Sales of the muscle relaxant Skelaxin climbed 37% to $99 million. Shares of King rose 7 cents, or 0.4%, to $18.11. The stock has almost doubled since Feb. ... TheStreet.com - TheStreet.com (subscription) King Pharmaceuticals Appoints Joseph Squicciarino Chief Financial … - Jun 1, 2005 ...topical, bovine, USP); dependence on King's ability to maintain effective patent protection for current formulations of Altace(R) and Skelaxin(R); ... $4.95 - PR Newswire - ECNext EDITED BRIEF - May 8, 2008 First question is regarding Skelaxin. Year over year prescriptions were down 8.5% ... Not too long ago Skelaxin was the only branded muscle relaxant in the ... $54.00 - Thomson StreetEvents - Alacra Store Arkansas Workers' Compensation Decisions - BOLT v. BAILEY PAINT CO … - Sep 17, 2008 The claimant was prescribed Skelaxin and Ultram on January 4, 2007 for chronic neck and back pain. The claimant was prescribed Tramadol on January 6, 2007. ... Pay-Per-View - Arkansas Workers' Compensation Decisions - Loislaw Loislaw Federal District Court Opinions - WOOD-MONROE v. ASTRUE ( … - Sep 16, 2008 Skelaxin was prescribed for pain, and Plaintiff reported that it helped with her discomfort ... Plaintiff's medications were recorded as: Skelaxin, Sudafed, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw United States 11th Circuit Court of Appeals Reports - MCDEVITT v. … - Jul 18, 2007 McDevitt told Friedenberg that he was taking hydrocodone, Neurontin, Phenergan, and Skelaxin. McDevitt also told Friedenberg that he was suffering ... Pay-Per-View - United States 11th Circuit Court of... - Loislaw Loislaw Federal District Court Opinions - JUSTINIANO v. ASTRUE ( … - Jan 18, 2008 He prescribed ibuprofen, Skelaxin and a requisition for physical therapy "with ... Dr. Singh switched her to Bextra and continued the Skelaxin, but noted ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Loislaw Federal District Court Opinions - RICHARDS v. COMMISSIONER … - Jul 14, 2008 Plaintiff takes Flexeril at bedtime and Skelaxin three times a day as a muscle relaxer. (TR 308). The Skelaxin and Vicodin make her drowsy. (TR 308). ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw King Pharmaceuticals Announces Appointment of Eric J. Bruce as … - Jun 10, 2005 ...topical, bovine, USP); dependence on King's ability to maintain effective patent protection for current formulations of Altace(R) and Skelaxin(R); ... $4.95 - PR Newswire - ECNext Colorado Industrial Claim Appeals Office Decisions - IN RE OF THE … - Dec 31, 2008 The ATP recommended continuing her post MMI medications, which included Skelaxin, Lortab, and Vioxx but also prescribed Prozac. In 2004, an ATP again noted ... Pay-Per-View - Colorado Industrial Claim Appeals... - Loislaw Loislaw Federal District Court Opinions - MARTIN v. ASTRUE (WDWis. 10... - Oct 4, 2007 He also refilled plaintiff's prescriptions for hydrocodone and Skelaxin. Plaintiff reported good relief from the injections. He did not return to the pain ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw King Pharmaceuticals Hit By Uncertainty - Mar 1, 2006 The Morgan Stanley analyst said uncertainty remains for the company's bestselling products, the cardiovascular drug Altace and Skelaxin, a muscle relaxer. ... Forbes King says Alpharma rebuffed a $1.4B buyout bid - Aug 22, 2008 King's key products include Avinza, which treats chronic pain and Skelaxin, a muscle relaxant. The drugs had sales of $653 million and $440 million, ... FOXNews Generic Threats Loom For King Pharmaceuticals - Feb 13, 2006 In addition, Saftlas said that King is facing generic threats to its muscle relaxant, Skelaxin. “On the plus side, we see much promise for Remoxy,â€? an ... Forbes FINAL TRANSCRIPT - May 8, 2008 First question is regarding Skelaxin. Year over year prescriptions were down 8.5% ... Not too long ago Skelaxin was the only branded muscle relaxant in the ... $54.00 - Thomson StreetEvents - Alacra Store Change For the Worse - Jun 19, 2006 King Pharmaceuticals (nyse: KG - news - people ) (17, KG ) faces patent expirations on its two biggest products, Skelaxin (muscle relaxant) in 2007 and ... Forbes King Must Sell Drug Assets to Buy Alpharma - Dec 26, 2008 King gets about half its revenue from sales of painkillers, but its muscle relaxant Skelaxin will face generic competition in 2012, and analysts say the ... TheStreet.com - TheStreet.com (subscription) Highlights of rising and falling US stocks - MarketWatch - May 3, 2005 Estimated wholesale inventory fell to 0.9 months from 1.7 for Altace, to 0.9 months from 1.1 months in Skelaxin, to 1.3 months from 1.7 months on Sonata, ... MarketWatch King seeks rehearing on Altace patent ruling - Sep 13, 2007 ...$21 in mid-July as investors have been concerned about the patent challenges to King's two biggest products -- Altace and the muscle relaxer Skelaxin. ... Reuters India King Shares Look Unattractive Based On Generic Threats - Mar 6, 2006 Also facing generic threats are King's Skelaxin, a muscle relaxant, and Sonata, a treatment for insomnia. Each is expected to face generic competition ... Forbes A Compelling Case for King Pharma - Feb 26, 2007 King also produces Skelaxin, a muscle relaxant (sales of $345 million in 2005); Thrombin-JMI, an acute care treatment ($221 million); Levoxyl, ... BusinessWeek Updates, advisories and surprises - Apr 12, 2005 It didn't forecast earnings for the year, due to the uncertainty about continued exclusivity of its Skelaxin muscle relaxant product. ... MarketWatch King Pharma options up on takeover talk-analysts - Nov 30, 2007 King's top two drugs are Altace, a treatment for high blood pressure and the muscle relaxer Skelaxin. The company's shares rose 2.42 percent, or 25 cents, ... Reuters Cephalon CEO looks ahead after settlement - Nov 20, 2007 N) Skelaxin, both of which are taken three times a day. "If you figure a 10 percent market share of the 47 million scripts in three years, that would not be ... Reuters Friday's Analysts' Upgrades and Downgrades - May 11, 2007 Market may also be too optimistic about the outlook for Skelaxin. Wendy's (WEN Quote) was downgraded to Hold at Citigroup. Valuation call, as the stock has ... TheStreet.com - TheStreet.com (subscription) What Are Muscle Relaxants And When Are They Used To Treat Pain? - Jan 2, 2008 Drugs like Soma, Flexeril, Robaxin, Skelaxin, and Norflex work at the spinal cord level and may add in relieving short-term muscle pain. ... ABC News Numbers That Blow You Away - Oct 17, 2005 Perhaps more important, sales of some products, such as Skelaxin, a muscle relaxant, and Levoxyl, a thyroid-hormone replacement, are proving stronger than ... BusinessWeek When pain arrives - and help does not - Sep 15, 2008 Skelaxin, a muscle relaxant, made me sleepy and nauseous. Percocet worked fairly well, but only for three hours at a time. Even the over-the-counter pills ... Boston Globe [U] Johnson v. Commissioner of Social Security, No. 06-5708 (DNJ... - Mar 11, 2008 Id. She was given Skelaxin, a muscle relaxant, four times a day. (R. 22; 143) Dr. Leifer also noted that her follow-ups had not been consistent. ... $2.95 - U.S. District Court, District of New... - VersusLaw Wyeth Cuts Sales Staff to Primary-Care Drs. | Article from AP Online... - Jun 20, 2005 The Bristol-based ... and the muscle relaxant Skelaxin _ and Elan' s primary care ... Article: King to Buy Sonata, Skelaxin Rights AP Online; January 30, ... Pay-Per-View - AP Online - HighBeam Research Janssen's Invega.(PRODUCT NEWS) | Article from Medical Marketing & … - Feb 1, 2007 Article: Skelaxin. (Product News).(from Elan in new ... Medical Marketing & Media; October 1, 2002 ; 604 words ...Elan has announced FDA approval for a new ... Pay-Per-View - Medical Marketing & Media - HighBeam Research GlaxoSmithKline.(Pipeline) | Article from Medical Marketing & Media |... - Aug 1, 2006 Article: Skelaxin. (Product News).(from Elan in new strength)(Brief ... Medical Marketing & Media; October 1, 2002 ; 604 words ...Elan has announced FDA ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Shire's Lialda.(PRODUCT NEWS) | Article from Medical Marketing & … - Mar 1, 2007 Article: Skelaxin. (Product News).(from Elan in new ... Medical Marketing & Media; October 1, 2002 ; 604 words ...Elan has announced FDA approval for a new ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Smith v. Astrue, No. 6:07-cv-06036 (WDArk. 05/02/2008) - May 2, 2008 ...[63], *fn9 Skelaxin is a muscle relaxant. See id. at 1752-1753. [64], *fn10 Plaintiff also claims the ALJ erred by not including in his opinion his reasons ... $2.95 - U.S. District Court, Western District... - VersusLaw Myers v. Astrue, No. A-07-CA-512 SS (WDTex. 03/04/2008) - Mar 4, 2008 ...that his "[p]ain is under control with skelaxin," Tr. 150, and that Plaintiff requested a muscle relaxant and anti-inflammatory for his back. Tr. 151. ... $2.95 - U.S. District Court, Western District... - VersusLaw Alpharma rejects sweetened bid - Sep 29, 2008 King, the Bristol, Tenn., maker of Skelaxin muscle relaxant and other drugs, initially proposed to acquire Alpharma for $33 a share in August. ... Tehran Times Article: Cephalon's revenue soars with Provigil. - Philadelphia... - Aug 4, 2006 1987, said he believes Cephalon can get "significant penetration ... helping drive sales growth at Cephalon. Baldino pointed to Skelaxin (metaxalone ... ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research 美법ì›?, 킹 ì œì•½ì‚¬ `알타세' 특허권 실효 íŒ?ê²° - Sep 12, 2007 ...ê·¸ ë?™ì•ˆ 투ìž?ìž?들ì?€ 알타세와 ìŠ¤ì¼ˆëž™ì‹ (Skelaxin) 등 킹 ì œì•½ì‚¬ì?˜ 대표ì ?ì?¸ ë‘? 약품 ì?˜ 특허권ì?´ 위기ì—? ì²˜í•´ìžˆë‹¤ê³ ìš°ë ¤í•´ 왔다. 킹 ì œì•½ì‚¬ 주가는 지난 7ì›” 중순 ì?´í›„ ... ì¡°ì„ ì?¼ë³´ Wednesday's biggest gaining and declining shares. - Feb 14, 2007 King Pharmaceuticals was upgraded to neutral from underweight by JP Morgan given its valuation and the possibility of a prolonged delay for generic Skelaxin ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Brown v. Barnhart, No. 4:04-cv-00545 (SDIowa 07/18/2005) - Jul 18, 2005 The PA prescribed Vioxx and Skelaxin. Tr. at 188-89. Plaintiff received physical therapy for her back on March 28 and April 4, 2002. Tr. at 216-20. ... $2.95 - U.S. District Court, Southern District... - VersusLaw Brand Names/Synonyms: Skelaxin is also known by the following brand names and/or synonyms.Meta.Xalon; .Meta.Xalone; .Meta.Zalone; .Meta.Zolone; AHR 438; AHR-438; HSDB 3236; Metassalone [Dcit]; Metaxalon; Metaxalona [Inn-Spanish]; Metaxalona [Spanish]; Metaxalone; Metaxalone [Usan:Ban:Inn]; Metaxalonum [Inn-Latin]; Metaxalonum [Latin]; Metazalone; Metazolone; Methaxalonum; Methoxolone; Skelaxin; Zorane Drug Category: Skelaxin is categorized under the following by the FDA: Muscle Relaxants, skeletal muscle; Analgesics; Hypnotics and Sedatives; Dosage Forms: Tablet Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
